Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free AVTX Stock Alerts

Avalo Therapeutics (AVTX) Short Interest Ratio & Short Volume

Avalo Therapeutics logo
$18.42 -0.49 (-2.59%)
Closing price 07/14/2026 04:00 PM Eastern
Extended Trading
$18.42 0.00 (0.00%)
As of 07/14/2026 06:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Avalo Therapeutics Short Interest Overview

As of June 30, 2026, Avalo Therapeutics (AVTX) had a short interest of 12.31 million shares sold short, representing 24.51% of the public float. This marks a 66.02% increase in short interest since the prior report. The short interest ratio (days to cover) is 4.3, meaning it would take 4.3 days of the average trading volume of 1.99 million shares to cover all short positions.

Current Short Interest
12,307,967 shares
Previous Short Interest
7,413,562 shares
Change Vs. Previous Month
66.02%
Dollar Volume Sold Short
$227.45 million
Short Interest Ratio
4.3 Days to Cover
Last Record Date
June 30, 2026
Outstanding Shares
52,570,000 shares
Short Percent of Float
24.51%
Today's Trading Volume
850,695 shares
Average Trading Volume
1,987,808 shares
Today's Volume Vs. Average
43%
Short Selling Avalo Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Avalo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AVTX Short Interest Over Time

AVTX Days to Cover Over Time

AVTX Percentage of Float Shorted Over Time

Avalo Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202612,307,967 shares $227.45 million +66.0%24.5%4.26 $18.48
6/15/20267,413,562 shares $108.24 million +16.2%14.8%5.53 $14.60
5/29/20266,382,270 shares $101.80 million +2.1%12.7%4.36 $15.95
5/15/20266,254,061 shares $110.95 million +9.1%12.5%1.59 $17.74
4/30/20265,733,586 shares $76.83 million +9.5%22.5%8.1 $13.40
4/15/20265,237,740 shares $69.92 million -5.5%10.4%6.12 $13.35
3/31/20265,542,400 shares $82.75 million +35.5%11.0%6.21 $14.93
3/13/20264,089,262 shares $64.61 million +11.1%22.1%5.83 $15.80
2/27/20263,681,926 shares $64.43 million +2.4%7.3%7.21 $17.50
2/13/20263,597,176 shares $51.30 million +13.0%7.2%9.44 $14.26
1/30/20263,183,754 shares $48.11 million +6.9%17.2%8.13 $15.11
1/15/20262,979,688 shares $46.60 million +16.0%16.1%10.17 $15.64
12/31/20252,568,740 shares $46.65 million +38.2%13.9%7.56 $18.16
12/15/20251,858,418 shares $32.89 million +0.5%10.3%5.96 $17.70
11/28/20251,848,452 shares $32.72 million +0.5%10.2%5.23 $17.70
11/14/20251,840,260 shares $27.81 million +36.8%10.2%4.84 $15.11
10/31/20251,345,096 shares $24.25 million +3.3%10.3%3.27 $18.03
10/15/20251,300,000 shares $18.07 million +4.8%12.3%3.6 $13.90
9/30/20251,240,000 shares $15.76 million +512.4%11.7%3.9 $12.71
9/15/2025202,500 shares $2.05 million +264.2%1.9%0.9 $10.14
8/31/202555,600 shares $516.52 thousand -38.4%0.5%0.3 $9.29
8/15/202590,200 shares $813.60 thousand +117.4%0.9%0.5 $9.02
7/31/202541,500 shares $327.44 thousand -74.7%0.4%0.3 $7.89
7/15/2025164,100 shares $787.68 thousand +38.1%1.9%1.8 $4.80
6/30/2025118,800 shares $592.81 thousand +41.8%1.4%1.5 $4.99
6/15/202583,800 shares $405.59 thousand +78.7%1.0%1.1 $4.84
5/31/202546,900 shares $185.26 thousand -45.8%0.5%0.5 $3.95
5/15/202586,500 shares $333.89 thousand +90.1%1.0%1.1 $3.86
4/30/202545,500 shares $226.59 thousand -54.7%0.5%0.7 $4.98
4/15/2025100,400 shares $491.96 thousand -13.2%1.2%1.4 $4.90
3/31/2025115,700 shares $926.76 thousand +20.3%1.4%1.6 $8.01
3/15/202596,200 shares $710.92 thousand +6.2%1.1%1 $7.39
2/28/202590,600 shares $662.29 thousand +19.2%1.1%0.9 $7.31
2/15/202576,000 shares $558.60 thousand +75.5%0.9%0.9 $7.35
1/31/202543,300 shares $364.59 thousand -22.4%0.5%0.5 $8.42
1/15/202555,800 shares $352.66 thousand +176.2%0.7%0.6 $6.32
12/31/202420,200 shares $150.09 thousand -11.8%0.2%0.2 $7.43
12/15/202422,900 shares $211.37 thousand +340.4%0.3%0.3 $9.23
11/30/20245,200 shares $49.66 thousand -46.9%0.1%0.1 $9.55
11/15/20249,800 shares $121.62 thousand -3.0%0.1%0.3 $12.41
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
10/31/202410,100 shares $131.40 thousand -79.5%0.1%0.4 $13.01
10/15/202449,200 shares $476.75 thousand -9.2%0.5%2.6 $9.69
9/30/202454,200 shares $514.90 thousand -8.9%0.6%3.1 $9.50
9/15/202459,500 shares $534.31 thousand +38.1%0.6%3.7 $8.98
8/31/202443,100 shares $301.70 thousand -23.6%5.0%2.4 $7.00
8/15/202456,400 shares $522.26 thousand -3.8%5.8%3.9 $9.26
7/31/202458,600 shares $666.87 thousand -9.6%6.0%3 $11.38
7/15/202464,800 shares $793.80 thousand -13.5%6.6%2.1 $12.25
6/30/202474,900 shares $934.00 thousand -0.7%7.7%1.4 $12.47
6/15/202475,400 shares $824.12 thousand -7.8%N/A0.1 $10.93
5/31/202481,800 shares $955.83 thousand -1.6%N/A0.1 $11.69
5/15/202483,100 shares $863.41 thousand -20.3%N/A0.1 $10.39
4/30/2024104,300 shares $1.79 million -32.0%N/A0.2 $17.12
4/15/2024153,400 shares $2.34 million +95.4%N/A0.2 $15.24
3/31/202478,500 shares $1.71 million +16.8%N/A0.1 $21.75
3/15/202467,200 shares $293.66 thousand +10.3%N/A1.3 $4.37
2/29/202460,900 shares $268.57 thousand -4.8%N/A0.7 $4.41
2/15/202464,000 shares $304.64 thousand -21.3%N/A0.7 $4.76
1/31/202481,300 shares $378.05 thousand -4.0%N/A0.8 $4.65
1/15/202484,700 shares $484.48 thousand +32.1%N/A0.7 $5.72
12/31/202364,100 shares $583.31 thousand -99.5%N/A0.4 $9.10
12/15/202312,640,000 shares $758.40 thousand +23.8%N/A0.2 $0.06
11/30/202310,210,000 shares $713.68 thousand -43.7%N/A0.1 $0.07
11/15/202318,140,000 shares $1.79 million +40.8%N/A0.2 $0.10
10/31/202312,880,000 shares $1.41 million +3.5%N/A0.2 $0.11
10/15/202312,450,000 shares $1.85 million -29.1%N/A0.2 $0.15
9/30/202317,550,000 shares $2.12 million +471.7%90.2%0.3 $0.12
9/15/20233,070,000 shares $406.78 thousand +220.1%15.8%0.1 $0.13
8/31/2023959,000 shares $95.90 thousand +0.2%5.2%0.1 $0.10
8/15/2023957,300 shares $134.02 thousand -10.5%5.2%0.2 $0.14
7/31/20231,070,000 shares $214 thousand +20.6%5.8%0.6 $0.20
7/15/2023887,000 shares $294.57 thousand +41.2%7.4%0.7 $0.33
6/30/2023628,400 shares $223.21 thousand +1,528.0%5.3%0.6 $0.36
6/15/202338,600 shares $145.33 thousand -9.4%0.4%0.1 $3.77
5/31/202342,600 shares $122.26 thousand -2.7%0.4%0.6 $2.87
5/15/202343,800 shares $120.45 thousand +17.1%0.4%0.9 $2.75
4/30/202337,400 shares $108.83 thousand -23.8%0.3%1.2 $2.91
4/15/202349,100 shares $127.66 thousand +172.8%0.4%1.7 $2.60
3/31/202318,000 shares $31.50 thousand -3.7%0.2%0.7 $1.75
3/15/202318,700 shares $46.84 thousand -24.6%0.2%1.1 $2.51
2/28/202324,800 shares $62.50 thousand +30.5%0.4%1.6 $2.52
2/15/202319,000 shares $56.24 thousand -32.4%0.3%1.3 $2.96
1/31/202328,100 shares $110.71 thousand -30.8%0.3%1.7 $3.94
1/15/202340,600 shares $197.32 thousand +17.0%0.5%2.7 $4.86
12/30/202234,700 shares $174.89 thousand -15.0%0.4%2.4 $5.04
12/15/202240,800 shares $237.86 thousand +9.4%0.5%3 $5.83
11/30/202237,300 shares $204.03 thousand +9.1%0.4%2.3 $5.47
11/15/202234,200 shares $198.36 thousand -3.1%0.4%1.7 $5.80
10/31/202235,300 shares $211.80 thousand -27.5%0.4%1.1 $6.00
10/15/202248,700 shares $258.11 thousand +10.9%0.6%1.4 $5.30
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
9/30/202243,900 shares $145.75 thousand -34.1%0.5%1.2 $3.32
9/15/202266,600 shares $279.05 thousand +26.1%0.8%1.3 $4.19
8/31/202252,800 shares $250.80 thousand -39.5%0.6%1 $4.75
8/15/202287,300 shares $467.93 thousand -10.9%1.0%1.6 $5.36
7/31/202298,000 shares $352.80 thousand +2.9%1.1%1.8 $3.60
7/15/202295,200 shares $437.92 thousand +26.8%1.1%1.9 $4.60
6/30/202275,100 shares $450.60 thousand -96.8%9.6%1.5 $6.00
6/15/20222,380,000 shares $1.09 million +10.2%2.3%4.1 $0.46
5/31/20222,160,000 shares $777.82 thousand +4.4%2.0%4.8 $0.36
5/15/20222,070,000 shares $517.29 thousand -0.5%2.0%4.7 $0.25
4/30/20222,080,000 shares $854.88 thousand +20.9%1.9%5.2 $0.41
4/15/20221,720,000 shares $1.03 million +19.4%1.5%4.5 $0.60
3/31/20221,440,000 shares $1.04 million +2.1%1.3%2.8 $0.72
3/15/20221,410,000 shares $913.40 thousand -0.7%1.3%2.7 $0.65
2/28/20221,420,000 shares $1.04 million +13.6%1.3%2.6 $0.73
2/15/20221,250,000 shares $1.13 million -17.2%1.1%2.4 $0.90
1/31/20221,510,000 shares $1.48 million -24.1%1.4%3 $0.98
1/15/20221,990,000 shares $1.99 million +28.4%1.8%3.9 $1.00
12/31/20211,550,000 shares $2.64 million No Change1.4%3.7 $1.70

AVTX Short Interest - Frequently Asked Questions

Short interest is the volume of Avalo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 12,307,967 shares of AVTX short. 24.51% of Avalo Therapeutics' shares are currently sold short. Learn More on Avalo Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVTX shares currently have a short interest ratio of 4.3. Learn More on Avalo Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 24.51% of Avalo Therapeutics' floating shares are currently sold short.

Avalo Therapeutics saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 12,307,967 shares, an increase of 66.0% from the previous total of 7,413,562 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

24.51% of Avalo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Avalo Therapeutics: Telix Pharmaceuticals Limited (0.05%), Denali Therapeutics Inc. (11.48%), NewAmsterdam Pharma Company N.V. (8.91%), Structure Therapeutics Inc. Sponsored ADR (9.12%), Catalyst Pharmaceuticals, Inc. (7.15%), Dyne Therapeutics, Inc. (14.90%), Arcus Biosciences, Inc. (11.12%), Beam Therapeutics Inc. (23.12%), Relay Therapeutics, Inc. (23.66%), Organon & Co. (6.61%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($82.01 billion), Invesco QQQ ($47.15 billion), iShares Russell 2000 ETF ($24.07 billion), Nebius Group N.V. ($16.85 billion), Western Digital Corporation ($14.29 billion), SPDR S&P Biotech ETF ($11.89 billion), VanEck Semiconductor ETF ($11.29 billion), KLA Corporation ($10.37 billion), iShares 20+ Year Treasury Bond ETF ($8.78 billion), and Lumentum Holdings Inc. ($8.29 billion). View all of the most shorted stocks.

Short selling AVTX is an investing strategy that aims to generate trading profit from Avalo Therapeutics as its price is falling. AVTX shares are trading down $0.49 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Avalo Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVTX, twice per month. The most recent reporting period available is June, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AVTX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:AVTX) was last updated on 7/10/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel